Search Results 141-150 of 17574 for colitis

  1. Gui Piovezani Ramos, M.D. - Doctors and Medical Staff - Mayo Clinic

    Complex Crohn's Disease and Ulcerative Colitis · Checkpoint-inhibitor colitis / enterocolitis · Mucosal Immunology · Personalized Medicine in IBD ...

  2. Low-fiber diet do's and don'ts - Mayo Clinic

    This may be due to a tumor or an inflammatory disease, such as Crohn's disease and ulcerative colitis. You have had bowel surgery. You are having treatment ...

  3. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

    Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).

  4. A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

    Ozanimod will be administered orally to pediatric participants with moderate to severe active Ulcerative Colitis who have had an inadequate response to ...

  5. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    This study is designed to evaluate the efficacy and safety of tofacitinib (CP-690,550) in patients with moderate to severe ulcerative colitis who have failed or ...

  6. A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) - Mayo Clinic

    A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) ... Colitis (UC) or Crohn's disease (CD).

  7. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis · Overview.

  8. Mirikizumab-mrkz (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Mirikizumab-mrkz injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...

  9. Doctors and departments - Mayo Clinic

    ... colitis. Publications. See a list of publications about pouchitis by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine. By Mayo ...

  10. Christina Y. Ha, M.D. - Doctors and Medical Staff - Mayo Clinic

    The goals of the inflammatory bowel disease care team are: To provide expertise in management of Crohn's disease and ulcerative colitis. To utilize multi- ...